Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in DSGN — Design Therapeutics, Inc.

CIK 1390777 NEW YORK, NY
Back to DSGN Full portfolio

Position in DSGN

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$1,332,237
+$484,816 QoQ
Shares Held
92,069
+15.6% QoQ
Ownership
0.147%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 136 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 76% Shared 0% None 24%

Common Shares in DSGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. DSGN ranks #180 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in DSGN

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,332,237 92,069
2026-03-31 $847,421 79,645
2025-12-31 $797,064 84,975
2025-09-30 $658,685 87,475
2025-06-30 $318,811 94,603
2025-03-31 $368,042 95,348
2024-12-31 $588,296 95,348
2024-09-30 $533,291 99,125
2024-06-30 $395,668 118,110
2024-03-31 $464,424 115,242
2023-12-31 $320,098 120,792
2023-09-30 $285,068 120,792
2023-06-30 $772,788 122,665
2023-03-31 $715,783 124,053
2022-12-31 $1,297,725 126,484
2022-09-30 $2,093,459 125,207
2022-06-30 $1,433,376 102,384
2022-03-31 $1,452,788 89,956
2021-12-31 $1,436,781 67,108
2021-09-30 $535,831 36,476
2021-06-30 $666,254 33,497